期刊文献+

卡托普利肾动态显像对老年人动脉粥样硬化性肾动脉狭窄的诊断价值 被引量:2

The role of captopril renal scintigraphy examination in diagnosing the atherosclerotic renal artery stenosis in the elderly
原文传递
导出
摘要 目的评估卡托普利肾动态显像诊断老年人动脉粥样硬化性肾动脉狭窄(ARAs)的价值。方法经肾动脉造影证实的肾动脉正常者22例(对照组)和28例老年ARAS患者(ARAS组)行卡托普利肾动态显像检查,评价卡托普利肾动态显像诊断ARAS的敏感性、特异性,并对其影响因素进行分析。结果卡托普利肾动态显像诊断ARAS的敏感性和特异性分别为71.4%和72.7%,卡托普利肾动态显像的4项诊断指标中,肾小球滤过率下降≥10%诊断的敏感性是46.4%,高于其他3项单项指标(P〈0.05);特异性为86.4%,与其他3项单项指标比较,差异无统计学意义。卡托普利肾动态显像诊断单侧ARAS的敏感性高于双侧,但差异无统计学意义(分别为85.7%与57.1%,P〉0.05)。肾小球滤过率中度以上降低(60~90ml·min^-1·1.73m^-2)的患者中,卡托普利肾动态显像诊断ARAS的敏感性高于肾小球滤过率轻度降低(〈60ml·min^-1·1.73m^-2)患者(分别为78.9%与55.6%,P〉0.05)。接受卡托普利肾动态显像检查的患者中未发生低血压等不良反应。结论卡托普利肾动态显像是一项较为安全、有效的诊断老年人ARAS的方法;应用二乙三胺五醋酸为显像剂,卡托普利肾动态显像时肾小球滤过率下降≥10%效果较好。 Objective To evaluate the diagnostic value of captopril renal scintigraphy (CRS) in the elderly with atherosclerotic renal artery stenosis (ARAS). Methods Twenty-two patients without renal artery stenosis and 28 patients with ARAS who underwent captopril renal scintigraphy after arteriography were enrolled in the study. The sensitivity and specificity of CRS for the diagnosis of ARAS were evaluated. Results The sensitivity and specificity of CRS for the diagnosis of ARAS were 71.4% and 72.7% respectively. The sensitivity of glomerular filtration rate decreased ≥10% in captopril renal scintigraphy as the criteria in diagnosing ARAS was 46.4%, which was significantly higher than that of other 3 criteria (all P〈0.05). The specificity was 86.4% which was not statistically significant (P〉0.05). The sensitivity of CRS for the diagnosis of ARAS was 57.1% in patients with bilateral renal artery stenosis and 85.7% in patients with unilateral renal stenosis, the difference was not statistically significant (P〉 0. 05). The sensitivity of CRS on the diagnosis of ARAS in the group of the moderately decreased GFR was not significantly different from the group of mild dcreased GFR (78.9% vs. 55.6%, P〉0.05). No clinically significant side effects such as hypotension happened during CRS examination in the study. Conclusions Captopril renal scintigraphy is a safe and well accurate examination for the diagnosis of atherosclerotic renal artery stenosis in elderly patients. 10% of decrease in calculated GFR of ipsilateral kidney after captopril intake is the most useful criteria in captopril renal scintigraphy when DTPA is used.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2008年第3期171-174,共4页 Chinese Journal of Geriatrics
关键词 动脉粥样硬化 肾动脉梗阻 卡托普利 Atherosclerosis Renal artery obstruction Captopril
  • 相关文献

参考文献16

  • 1王芳,王梅,王海燕.动脉粥样硬化患者肾动脉狭窄患病率的调查[J].中华肾脏病杂志,2005,21(3):139-142. 被引量:66
  • 2Taylor AT, Fletcher JW, Nally JV, et al. Procedure guideline for diagnosis of renovascular hypertension. J Nucl Med, 1998,7:1297-1302.
  • 3Majd M, Potter BM, Guzetta PC, et al. Effect of captopril on efficacy of renal scintigraphy in detection of renal artery stenosis. J Nucl Med, 1983,24 : 23.
  • 4Blaufox MD,Fine EJ, Heller S, et al. Prospective study of simultaneous orthoiodohippurate and diethylenet riaminepentaacetic acid captopril renography. J Nucl Med, 1998,3 : 522-528.
  • 5Dondi M, Monetti N, Fanti S, et al. Use of ^99m Tc-MAG3 for renal scintigraphy after angiotensin-converting enzyme inhibition. J Nucl Med, 1991,32:424-428.
  • 6Blaufox MD,Dubovsky EV, Hilson AJ,et al. Report of the working party group on determining the radionuclide of choice. Am J Hypertens, 1991, 4: 747-748.
  • 7Taylor A,Nally J, Aurell M, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. J Nucl Med, 1996,37 : 1876-1882.
  • 8Bongers V, Bakker J, Beutler JJ, et al. Assessment of renal artery stenosis : comparison of captopril renography and gadolinium-enhanced breath-hold MR angiography. Clin Radiol, 2000,55 : 346-353.
  • 9Setaro JF, Chen CC, Holler PB, et al. Captopril renography in the diagnosis of renal artery stenosis and the prediction of improvement with revascularization. The Yale Vascular Center experience. Am J Hypertens,1991,4 (12 Pt 2) :698S-705S.
  • 10Robert D, Safian MD, Stephen C, et al. Renal-artery stenosis. N Engl J Med,2001,344:431-442.

二级参考文献16

  • 1Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal disease, incidence,clinical correlates, and outcomes:a 20-year clinical experience.Am J Kidney Dis, 1994,24:622-629.
  • 2Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol, 1998,9:252-256.
  • 3Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol,1992,2:1608-1616.
  • 4Vetrovec GW, Landwehr DM, Edwards VL. Incidence of renal artery stenosis in hypertensive patients undergoing coronary angiography.J Intervent Cardio, 1989,2:69-76.
  • 5Setsuko K, Naoki N, Takashi U. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke, 2000,31:61.
  • 6Choudhri AH, Cleland JG, Rowlands PC, et al. Unsuspected renal artery stenosis in peripheral vascular disease. Br J Med,1990,301:1197-1198.
  • 7Salmon P, Brown MA. Renal artery stenosis and peripheral vascular disease: implication for ACE inhibitor therapy.Lancet, 1990,336:321.
  • 8Crook E. The role of hypertension, obesity, and diabetes in causing renal vascular disease. Am J Med, 1999, 317:183-188.
  • 9Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.JAMA,1997, 277:1775-1781.
  • 10Christen WG, Ridker PM. Blood levels of homocysteine and atherosclerotic vascular disease. Curr Atheroscler Rep, 2000,2:194-1991.

共引文献65

同被引文献8

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部